Hiro Shimada
Impact in
- Neurology top 1%
- Neuroblastoma Research and Treatments
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Neuroblastoma Research and Treatments 4
-
- Cancer Genomics and Diagnostics 1
- Co-authors
- John M. Maris (3 shared papers)Katherine K. Matthay (3 shared papers)Judith Grob Villablanca (3 shared papers)C. Patrick Reynolds (2 shared papers)Susan Lerner Cohn (2 shared papers)Ralph A. Reisfeld (1 shared paper)Wendy B. London (1 shared paper)Alice Lin-Tsing Yu (1 shared paper)
- Journals
- Pediatric Blood & Cancer (1 paper)Cancer Research (1 paper)Transplantation and Cellular Therapy (1 paper)Journal of Microscopy (1 paper)Journal of Pediatric Surgery (1 paper)
- Partner nations
- United StatesSwitzerlandTaiwan
In The Last Decade
Hiro Shimada
12 papers receiving 1.9k citations
Hiro Shimada's Hit Papers
Peers
Comparison fields: 5 of 84
- Neurology 1.1k
- Cancer Research 302
- Oncology 494
- Immunology 301
- Genetics 132
Countries citing papers authored by Hiro Shimada
This map shows the geographic impact of Hiro Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiro Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiro Shimada more than expected).
Fields of papers citing papers by Hiro Shimada
This network shows the impact of papers produced by Hiro Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiro Shimada. The network helps show where Hiro Shimada may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiro Shimada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma Hit paper breakdown → | 2010 | 1438 |
| 2 | 2008 | 116 | |
| 3 | 2006 | 85 | |
| 4 | 2016 | 81 | |
| 5 | 2015 | 74 | |
| 6 | 2006 | 68 | |
| 7 | 2010 | 21 | |
| 8 | 1999 | 14 | |
| 9 | 2016 | 8 | |
| 10 | 2006 | 7 | |
| 11 | 1999 | 2 | |
| 12 | Study of Electromagnetic Analysis Method in Large Indoor Space | 2019 | 1 |
About Hiro Shimada
Hiro Shimada is a scholar working on Neurology, Cancer Research, Biophysics, Media Technology and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 1.9k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (4 papers), Sarcoma Diagnosis and Treatment (1 paper), Fungal Infections and Studies (1 paper), Cancer Genomics and Diagnostics (1 paper), Cancer Cells and Metastasis (1 paper), Plant Pathogens and Fungal Diseases (1 paper), Plant Disease Resistance and Genetics (1 paper) and Renal and Vascular Pathologies (1 paper). The work is most often cited by research in Neurology (1.1k citations), Cancer Research (302 citations), Oncology (494 citations), Immunology (301 citations) and Genetics (132 citations). Hiro Shimada has collaborated with scholars based in United States, Switzerland and Taiwan. Frequent co-authors include John M. Maris, Katherine K. Matthay, Judith Grob Villablanca, C. Patrick Reynolds, Susan Lerner Cohn, Ralph A. Reisfeld, Wendy B. London, Alice Lin-Tsing Yu, Malcolm Anders Smith and Barry Douglas Anderson. Their work appears in journals such as Pediatric Blood & Cancer, Cancer Research, Transplantation and Cellular Therapy, Journal of Microscopy and Journal of Pediatric Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.